Category: Press Release

2021.02.09

Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced

2021.02.05

Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Selling Shareholders of I-Mab

2021.02.05

I-Mab Announces Multiple Clinical Advancements of its Differentiated CD73 Antibody Uliledlimab in China and the U.S.

2021.02.04

I-Mab Announces First Patient Dosed in Phase 2 Clinical Trial of TJ107 in Glioblastoma Multiforme in China

2021.01.25

I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer

2020.12.24

I-Mab Announces Upcoming Participation at January Conferences

2020.12.14

I-Mab Added to Nasdaq Biotechnology Index

2020.12.04

I-Mab Accelerates Clinical Development of Anti-CD47 Monoclonal Antibody Lemzoparlimab in the US and China

2020.12.01

I-Mab Files Shelf Registration Statement for PIPE Investors

2020.12.01

I-Mab Appoints Leading Immunology and Hematology Experts to its Scientific Advisory Board